CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-23 | CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO | Grant or award | +54,470 | 117,615 | ||
| 2021-03-23 | Lalwani Nikhil PRESIDENT & CEO | Grant or award | +136,495 | 165,003 | ||
| 2021-03-23 | Pera Antonio R Director | Grant or award | +9,292 | 16,713 | ||
| 2021-03-23 | Thoma Jeanne Director | Grant or award | +9,292 | 16,713 | ||
| 2021-03-23 | NASH DAVID Director | Grant or award | +9,292 | 21,647 | ||
| 2021-03-23 | HAUGHEY THOMAS Director | Grant or award | +9,292 | 27,702 | ||
| 2021-03-23 | Brown Robert E. JR Director | Grant or award | +9,292 | 38,972 | ||
| 2021-03-23 | Walsh Patrick D Director | Grant or award | +9,292 | 48,388 | ||
| 2021-03-15 | Walsh Patrick D Director | Purchase | +4,000 | $32.89 | $132K | 39,096 |
| 2021-02-15 | Mutz Christopher CHIEF COMMERCIAL OFFICER | Grant or award | +16,134 | 16,134 | ||
| 2021-02-15 | Mutz Christopher CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (right to buy) | +33,758 | 33,758 | ||
| 2021-02-15 | Gutwerg Ori SVP, GENERICS | Grant or award | +12,907 | 12,907 | ||
| 2021-02-15 | Gutwerg Ori SVP, GENERICS | Grant or award · Stock Option (right to buy) | +27,006 | 27,006 | ||
| 2020-11-09 | Walsh Patrick D Director | Purchase | +5,000 | $25.96 | $130K | 35,096 |
| 2020-09-08 | Lalwani Nikhil PRESIDENT & CEO | Grant or award | +28,508 | 28,508 | ||
| 2020-09-08 | Lalwani Nikhil PRESIDENT & CEO | Grant or award · Stock Option (right to buy) | +179,643 | 179,643 | ||
| 2020-08-10 | Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO | Purchase | +3,000 | $30.40 | $91K | 23,096 |
| 2020-08-10 | Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO | Purchase | +4,000 | $30.98 | $124K | 27,096 |
| 2020-08-10 | Walsh Patrick D CHAIRMAN, INTERIM PRES. & CEO | Purchase | +3,000 | $30.89 | $93K | 30,096 |
| 2020-08-05 | Pera Antonio R Director | Grant or award | +7,421 | 7,421 |
Page 25 of 31 · 601 trades